Non-Canonical Hh Signaling in Cancer—Current Understanding and Future Directions
As a major regulatory pathway for embryonic development and tissue patterning, hedgehog signaling is not active in most adult tissues, but is reactivated in a number of human cancer types. A major milestone in hedgehog signaling in cancer is the Food and Drug Administration (FDA) approval of a smoot...
Main Authors: | Dongsheng Gu, Jingwu Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/7/3/0857 |
Similar Items
-
Recent Advances in the Clinical Targeting of Hedgehog/GLI Signaling in Cancer
by: Hao Xie, et al.
Published: (2019-04-01) -
Non-canonical Hedgehog Signaling Pathway in Cancer: Activation of GLI Transcription Factors Beyond Smoothened
by: Silvia Pietrobono, et al.
Published: (2019-06-01) -
Hedgehog Pathway Blockade Inhibits Melanoma Cell Growth in Vitro and in Vivo
by: Eva Hernando, et al.
Published: (2013-11-01) -
Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors
by: Tadas K. Rimkus, et al.
Published: (2016-02-01) -
Hedgehog signaling is a potent regulator of liver lipid metabolism and reveals a GLI-code associated with steatosis
by: Madlen Matz-Soja, et al.
Published: (2016-05-01)